False-positive point-of-care urine beta human chorionic gonadotropin testing: Insights from two clinical cases

View at publisher Summarise with VIRAT
Authors: Gayani Nilmini Dissanayake, Hanine Fourie, Gordana Fricker, Darmiga Thayabaran, Mayur Patel, Ingrid Granne, Brian S. F. Shine
Cited by: 0
References: 7

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Case one A young woman presented to the Early Pregnancy Assessment Unit (EPAU) with abdominal pain, amenorrhoea and variably positive home-pregnancy tests. On review, a point-of-care test (POCT) for urine beta-HCG (β-HCG) was negative but a blood test using the Abbott i-STAT β-HCG POCT device was positive. Initial transvaginal ultrasound did not demonstrate an intra- or extra-uterine pregnancy. Over the following 2 months, weekly plasma POCT iSTAT β-HCG checks remained positive. After a further ultrasound suggesting a possible ectopic pregnancy, the patient underwent a diagnostic laparoscopy which was unremarkable. Post-operatively, POCT iSTAT β-HCG levels remained elevated, and a blood sample was sent for laboratory analysis revealing an undetectable β-HCG of

Fields of Study & Subjects

Clinical Laboratory Practices and Quality Control Gestational Trophoblastic Disease Studies Reproductive Health and Contraception

Publication details

Journal / source
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
Volume
63
Issue
5
Pages
458–461
Publication date
21 March 2026
Language
EN